A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Name: A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
License: Public Domain

Nationwide Children's Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pediatric sarcoma, refractory, pediatric sarcoma, relapsed

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353272
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.